Product Information

BEPOTASTINE 1.5% EYE DROP is a generic product labeled by Bausch & Lomb Incorporated, priced at $9.4573 per ML under NDC 24208063005. Its NADAC has been published 275 times since Aug 18, 2021.

FDA first approved this application on Sep 8, 2009. Its Orange Book therapeutic-equivalence code is AT.

The High Outlier badge above means this manufacturer's average price in the bepotastine besilate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

BEPOTASTINE 1.5% EYE DROP

bepotastine besilate
$9.4573per ML
High Outlier

Strength

15 mg/mL

NDC

24208063005

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

BEPOTASTINE BESILATE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA022288

FDA Approved

9/8/2009

TE Code

AT

On Market Since

5/28/2021

Pharmacological Classes

Price Statistics

The NADAC for BEPOTASTINE 1.5% EYE DROP has been published 275 times since Aug 18, 2021, and over the history we have for it it has declined 75.3%. The table below summarizes its recorded NADAC range and movement.

Current price$9.4573 per ML
All-time high$38.6198 (Dec 15, 2021)
All-time low$9.4573 (Nov 18, 2026)
52-week high$14.6492
52-week low$9.4573
Median price$18.8371
Average price$20.2195
Largest weekly change+49.6% (Nov 20, 2024)
Weeks tracked275
Tracking sinceAug 18, 2021

Price History

1W

-3.8%

1M

-9.8%

3M

-16.0%

6M

-25.3%

1Y

-28.9%

3Y

-48.7%

5Y

-75.5%

All

-75.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BEPOTASTINE 1.5% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for BEPOTASTINE 1.5% EYE DROP, manufactured by Bausch & Lomb Incorporated, is $9.4573 per ML (NDC 24208063005), effective Nov 18, 2026.

How has the price of BEPOTASTINE 1.5% EYE DROP changed over time?

Over the history we have for it, the NADAC for BEPOTASTINE 1.5% EYE DROP has declined 75.3%. It has been tracked across 275 weekly CMS publications since Aug 18, 2021.

What are the highest and lowest recorded NADAC prices for BEPOTASTINE 1.5% EYE DROP?

Since Aug 18, 2021, the NADAC for BEPOTASTINE 1.5% EYE DROP has ranged from a low of $9.4573 (Nov 18, 2026) to a high of $38.6198 (Dec 15, 2021), with a median of $18.8371 per ML.

Are there cheaper alternatives to BEPOTASTINE 1.5% EYE DROP?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BEPOTASTINE 1.5% EYE DROP, is $8.0874 per ML — about 14% below BEPOTASTINE 1.5% EYE DROP.

Who manufactures BEPOTASTINE 1.5% EYE DROP?

BEPOTASTINE 1.5% EYE DROP (NDC 24208063005) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.